IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection

NACompletedINTERVENTIONAL
Enrollment

629

Participants

Timeline

Start Date

January 31, 2005

Study Completion Date

October 31, 2009

Conditions
Graft RejectionHeart Diseases
Interventions
DEVICE

AlloMap molecular expression testing

PROCEDURE

Right ventricular endomyocardial biopsy

Trial Locations (13)

10032

Columbia University Medical Center - New York Presbyterian Hospital, New York

15213

University of Pittsburgh Medical Center, Pittsburgh

19104

University of Pennsylvania, Philadelphia

44195

The Cleveland Clinic, Cleveland

60611

Northwestern University, Chicago

60637

University of Chicago, Chicago

63110

Barnes Jewish Hospital - Washington University, St Louis

64111

Mid America Heart Institute - St. Luke's Hospital, Kansas City

77030

Texas Heart Institute at St. Luke's Episcopal Hospital, Houston

84157

Intermountain Medical Center, Murray

94304

VA Palo Alto Health Care System, Palo Alto

94305

Stanford University Medical Center, Stanford

07112

Newark Beth Israel Medical Center, Newark

Sponsors

Lead Sponsor

All Listed Sponsors
lead

XDx

INDUSTRY

NCT00351559 - IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection | Biotech Hunter | Biotech Hunter